Equitable Holdings’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.21M Sell
18,701
-95
-0.5% -$21.2K 0.02% 576
2025
Q4
$3.22M Buy
18,796
+890
+5% +$138K 0.02% 494
2025
Q3
$2.4M Buy
17,906
+285
+2% +$30.2K 0.02% 549
2025
Q2
$1.72M Buy
17,621
+11,652
+195% +$924K 0.01% 618
2025
Q1
$434K Buy
5,969
+2,187
+58% +$172K ﹤0.01% 960
2024
Q4
$273K Buy
3,782
+192
+5% +$14.6K ﹤0.01% 1076
2024
Q3
$293K Sell
3,590
-640
-15% -$55.6K ﹤0.01% 1048
2024
Q2
$450K Buy
4,230
+160
+4% +$15.3K ﹤0.01% 868
2024
Q1
$395K Buy
4,070
+270
+7% +$23.8K ﹤0.01% 885
2023
Q4
$297K Buy
3,800
+180
+5% +$12.3K ﹤0.01% 941
2023
Q3
$227K Buy
+3,620
New +$238K ﹤0.01% 960
2022
Q4
Sell
-7,050
Closed -$258K 931
2022
Q3
$258K Buy
+7,050
New +$314K 0.01% 729
2020
Q1
Sell
-11,280
Closed -$330K 609
2019
Q4
$330K Buy
+11,280
New +$300K 0.01% 480

Other funds holding LRCX

Equitable Holdings's LRCX Position: Q1 2026 in Review

Equitable Holdings reduced its Lam Research (LRCX) stake by 0.51% in Q1 2026, selling an estimated $21.2K and leaving 18,701 shares worth $3.21M. The position accounts for 0.02% of the portfolio, ranked #576.

Equitable Holdings first reported a position in LRCX in Q4 2019 and has held it in 13 quarters since. The position peaked at $3.22M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Equitable Holdings held 18,701 shares of Lam Research worth $3.21M as of Q1 2026.
  • Equitable Holdings sold 95 Lam Research shares in Q1 2026, an estimated $21.2K.
  • Lam Research made up 0.02% of Equitable Holdings's portfolio in Q1 2026, its #576 holding.
  • Equitable Holdings first reported a position in Lam Research in Q4 2019 and has held it in 13 quarters since.
  • Equitable Holdings's Lam Research position peaked at $3.22M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.